References

  1. Coopman V, Cordonnier J, Pien K, Varenberghb DV. LC–MS/MS analysis of fentanyl and norfentanyl in a fatality due to application of multiple Durogesic® transdermal therapeutic systems. Forensic Science International. 2007 Jul 4;169(2-3):223-7. PubMed | Google Scholar

  2. Bullingham RES. Opiate analgesia. London, UK: Saunders; 1983. Google Scholar

  3. Roy SD, Flynn GL. Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin. Pharm Res. 1989 Oct;6(10):825-32. PubMed | Google Scholar

  4. Mary Lynn Arvanitis and coll. Transdermal fentanyl abuse and misuse. American Journal of Emergency Medicine. 2002; 20(1):58-59. PubMed | Google Scholar

  5. Marquaardt KA, Tharratt RS. Inhalation abuse of fentanyl patch. J Toxicol Clin Toxicol. 1994;32(1):75-8. PubMed | Google Scholar

  6. DeSio JM, Bacon DR, Peer G, Lema MJ. Intravenous abuse of transdermal fentanyl therapy in a chronic pain patient. Anesthesiology. 1993 Nov;79(5):1139-41. PubMed | Google Scholar

  7. Edinboro LE, Poklis A, Trautman D, Lowry S, Backer R, Harvey CM. Fatal fentanyl intoxication following excessive transdermal application. J Forensic Sci. 1997 Jul;42(4):741-3. PubMed | Google Scholar

  8. Kramer C, Tawney M. A fatal overdose of transdermally administered fentanyl. J Am Osteopath Assoc. 1998 Jul;98(7):385-6. PubMed | Google Scholar

  9. Purucker M, Swann W. Potential for duragesic patch abuse. Ann Emerg Med. 2000 Mar;35(3):314. PubMed | Google Scholar

  10. Marquardt KA1, Tharratt RS, Musallam NA.Fentanyl remaining in a transdermal system following three days of continuous use. Ann Pharmacother. 1995 Oct;29(10):969-71. PubMed | Google Scholar

  11. Inturrisi CE. Clinical pharmacology of opioids fot pain. Clin J Pain. 2002; 18:S3-13. PubMed | Google Scholar

  12. Moon JM, Chun BJ, Fentanyl Intoxication Caused by Abuse of Transdermal Fentanyl. Journal of Emergency Medicine. 2011 Jan;40(1):37-40. Google Scholar